| 000 | 01768 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517071550.0 | ||
| 264 | 0 | _c20161213 | |
| 008 | 201612s 0 0 eng d | ||
| 022 | _a1752-8984 | ||
| 024 | 7 |
_a10.1177/1479164115618517 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSalahuddin, Usman I | |
| 245 | 0 | 0 |
_aEffect of treatment with rosiglitazone on high-sensitivity cardiac troponin levels among patients with type 2 diabetes mellitus. _h[electronic resource] |
| 260 |
_bDiabetes & vascular disease research _cMar 2016 |
||
| 300 |
_a113-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCoronary Artery Disease _xcomplications |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xcomplications |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Failure _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyocardial Infarction _xcomplications |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aRosiglitazone |
| 650 | 0 | 4 |
_aThiazolidinediones _xadverse effects |
| 650 | 0 | 4 |
_aTroponin _xblood |
| 700 | 1 | _aPandey, Ambarish | |
| 700 | 1 | _aAyers, Colby R | |
| 700 | 1 | _aSee, Raphael | |
| 700 | 1 | _aNeeland, Ian J | |
| 700 | 1 | _aGore, M Odette | |
| 700 | 1 | _aGrinsfelder, D Bennett | |
| 700 | 1 | _aAbdullah, Shuaib M | |
| 700 | 1 | _aKhera, Amit | |
| 700 | 1 | _ade Lemos, James A | |
| 700 | 1 | _aMcGuire, Darren K | |
| 773 | 0 |
_tDiabetes & vascular disease research _gvol. 13 _gno. 2 _gp. 113-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/1479164115618517 _zAvailable from publisher's website |
| 999 |
_c25573685 _d25573685 |
||